Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Delayed Data
As of Mar 28
 -1.38 / -1.18%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 184.00, with a high estimate of 332.00 and a low estimate of 60.00. The median estimate represents a +58.91% increase from the last price of 115.79.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Buy stock in Intercept Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.45%
Growthannually 1.83%


Growthquarterly 14.62%
Growthannually 321.49%
Key to the earnings and sales forecast charts.